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This systematic review aimed to determine the effectiveness of interventions for improving 
knowledge and/or self-management skills concerning contraception, pregnancy and breastfeeding 
in people with rheumatoid arthritis (RA).  We searched 4 databases (Medline, CINAHL, Cochrane 
Trials, PsycInfo) using a comprehensive search strategy.  Studies were eligible if they were 
prospective, published in English from 2004-2015, included participants with RA, and tested an 
intervention designed to improve knowledge and/or self-management skills relating to family 
planning, pregnancy or breastfeeding.  As no studies met the latter criterion, the search strategy 
was expanded to include all prospective studies evaluating RA educational and/or self-
management interventions.  Data on study characteristics, participant characteristics and program 
content were extracted to summarise the evidence base for interventions to support people with 
RA during their reproductive years.  Expanded literature searches identified 2290 papers, of which 
68 were eligible. Of these, 9 papers (13%) specifically excluded pregnant women/breastfeeding 
mothers or recruited only older people.  Only 1 study (1%) explicitly evaluated pregnancy-focused 
education via a motherhood decision aid, while 8 studies (12%) incorporated relevant (albeit minor) 
components within broader RA educational or self-management interventions.  Of these, 3 studies 
provided methotrexate education in relation to conception/pregnancy/breastfeeding; 3 incorporated 
discussions on RA and relationships, impact of RA on the family, or sexual advice; 1 provided 
information regarding contraception and fertility; and 1 issued a warning regarding use of biologic 
therapy in pregnancy/breastfeeding.  In conclusion, information regarding family planning, 
pregnancy or breastfeeding represents a negligible part of published RA educational interventions, 
with scope to develop targeted resources. 
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Rheumatoid arthritis (RA) substantially impacts women of reproductive age [1], and the symptoms 
and physical limitations associated with the disease, as well as the potential side-effects of 
disease-modifying medications, represent important considerations in family planning and disease 
management in early parenting [2-4].  Pregnancy raises a plethora of complex issues for women 
with RA and their families to consider, particularly around the cessation of medications, the 
management of disease flares, and the effects of drug exposure on an unborn baby or breastfed 
child [5].  Disease management approaches will usually need to be modified over the course of 
pregnancy and breastfeeding and as some disease-modifying anti-rheumatic drugs (DMARDs) are 
teratogenic (such as methotrexate), education regarding effective contraception and avoidance of 
unplanned pregnancy is also critical for people with RA during their reproductive years [4,6].  Our 
recent qualitative research found that the lack of accessible and specific information concerning 
the safety and toxicity of RA medications was the most important issue reported by women who 
were pregnant, planning a pregnancy, or who had been pregnant in the last five years [7].  
Receiving inconsistent advice from health professionals concerning pharmacological management 
of their RA was a major source of frustration and confusion for many women, and a desire for 
enhanced peer support and practical education to support women in caring for their young baby 
was also emphasised.  There is, then, a clear need for appropriate education and support for 
women with RA (and their families) who are contemplating pregnancy, currently pregnant or 
breastfeeding to provide a more informed and acceptable patient journey.  
 
Patient education is considered an integral part of routine care for people with inflammatory 
arthritis [8] and this can be complemented by self-management training to enhance knowledge and 
skills and empower people to better manage their health across the disease continuum.  Although 
many diverse models exist, perhaps the most well-known programs internationally are the Stanford 
Arthritis Self-Management Program and the Chronic Disease Self-Management Program 
developed by Lorig and colleagues [9].  Self-management interventions commonly cover a range 




with health professionals, while aiming to influence health attitudes, beliefs and behaviours [10].  
To date, systematic reviews of patient education and self-management interventions in RA 
(including one Cochrane review) have all been broad in scope and have not focused on the 
specific needs of women who are pregnant or considering pregnancy [8,10-13], despite emerging 
evidence that this group of patients have specific educational needs [7,14].  The content and 
outcomes of educational interventions for this patient group therefore remain unknown.  This 
systematic review aimed to evaluate the effectiveness of interventions designed to improve 
knowledge and/or self-management skills concerning contraception, pregnancy and breastfeeding 






A systematic review was undertaken and documented according to the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) checklist [15]. 
 
Search strategy 
Four key electronic databases were searched from January 2004 to March 2015 to identify 
potentially relevant studies (Cochrane Controlled Trials Register, Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), MEDLINE and PsycInfo).  A standardised search strategy was 
based on that used for an earlier Cochrane review of patient education for adults with RA [11], with 
the addition of specific search terms relating to pregnancy, breastfeeding/lactation/nursing, 
conception, contraception and family planning:  
 
(rheumatoid arthritis OR arthritis) AND (clinical trial OR study OR evaluation OR 
program OR experiment) AND (health promotion OR patient education OR behavior 
therapy OR behaviour therapy OR occupational therapy OR self care OR 
psychological adaptation OR counseling OR counselling) AND (pregnan* OR lactat* 
OR breast* OR nursing mother OR conception OR contracept* OR family planning) 
NOT review   
 




To be eligible for inclusion in the review, studies were required to have: used a prospective design 
(not limited to randomised controlled trials), been published in English since 2004, included 
participants with RA, and tested an intervention designed to improve knowledge and/or self-




to 2004 were excluded to optimise relevance of the findings given significant changes in the 
pharmacological management of RA over the past decade [16] and the potential impact of these 
changes on the content of disease-related education. 
 
Selection of studies and revision of search strategy 
All titles and abstracts identified from the database searches were screened independently by 2 
reviewers.   As no studies were identified that met the intervention criterion, the search strategy 
was revised and a broader search was conducted across the same 4 electronic databases to 
identify all prospective studies evaluating educational and/or self-management interventions for 
people with RA that were published in English from January 2004 to March 2015.  The following 
search strategy was used:  
 
(rheumatoid arthritis OR arthritis) AND (clinical trial OR study OR evaluation OR 
program OR experiment) AND (health promotion OR patient education OR behavior 
therapy OR behaviour therapy OR occupational therapy OR self care OR 
psychological adaptation OR counseling OR counselling) NOT review 
 
Titles and abstracts retrieved from the second literature search were also screened independently 
by 2 reviewers according to the revised inclusion criteria, and the full texts of eligible papers were 
obtained.  Where eligibility was unclear from title and abstract screening, the full text was obtained.  
Two reviewers independently reviewed the full text papers to confirm eligibility, with any 
discordance resolved through discussion (with referral to a third independent reviewer, where 
required).  Where two or more papers derived from the same study clearly met the inclusion criteria 
(for example, follow-up studies reporting longer-term outcomes or additional interventions) each 
paper was included in the review but their relationship was noted (Online Resource 1).  The 
reference lists of all included papers were also screened to identify any additional papers that met 




New Zealand Clinical Trials Registry websites (www.anzctr.org.au) were also searched to identify 
registered trials of relevance, and related publications (where available) were obtained. 
 
Data extraction 
The following data were independently extracted by 2 reviewers from all included studies: 
 relevant participant exclusion criteria (pregnancy or breastfeeding status, age restrictions); 
 participant characteristics (sample size, proportion of female participants, age of 
participants, proportion of sample with a diagnosis of RA); and  
 whether the intervention(s) included an educational and/or self-management component 
relating to contraception, conception, pregnancy and/ or breastfeeding.   
 
Any disagreements were resolved through discussion in order to reach consensus, and a third 
independent reviewer was enlisted where required.  Information about the use of outcome 
measures relevant to conception/pregnancy/breastfeeding knowledge was also extracted from 
studies where interventions included a pregnancy-related component.  Outcomes data were not 
extracted from included studies because for most studies the effect of individual program 
components could not be determined (for example, the effect of specific education related to 
pregnancy).  Where information provided in a published paper was unclear, clarification was 






Figure 1 provides an overview of the study screening and selection process.  In total, 2290 
potentially eligible papers were identified from the revised database searches.  After excluding 143 
duplicate papers and 2073 papers that did not meet the eligibility criteria, 74 full text papers were 
retrieved to confirm their eligibility. Of these, a further 11 papers were excluded, including 2 papers 
where it was not clear that people with RA were included in the study sample (1 study included 
people with any type of arthritis or persistent joint pain but the proportion of participants with RA 
was not reported; 1 study included people with rheumatic diseases but the proportion of 
participants with RA was not reported).  Screening of reference lists and searches of clinical trial 
registries identified 5 additional eligible papers, resulting in a total of 68 papers included in the 
review.  
 
Characteristics of included studies 
As shown in Table 1, the majority of included studies were randomised controlled trials (n=45, 
66%).  Non-randomised prospective designs (including single group pretest-posttest designs) were 
also common (n=19, 28%) while only 1 study used a mixed-methods design.  Most studies were 
conducted in Europe (n=30, 44%), followed by North America (n=28, 41%).  The included studies 
were undertaken in a range of healthcare and community settings including hospitals or clinics, 
community health or rehabilitation centres and the general community.  Table 1 summarises the 
age, gender and diagnosis characteristics of all participants in the included studies. Forty-five 
studies (66%) recruited people with RA only (or people with RA and their partners), while the 
remaining 23 studies included a broader range of diagnoses including RA.  A detailed summary of 
each of the 68 included studies (including information about interventions and controls) is provided 





Studies with exclusion criteria related to pregnancy, breastfeeding or age  
Of the included papers, 3 specifically excluded pregnant women or breastfeeding mothers [17-19] 
and one recruited only participants who were rheumatologist-confirmed candidates for 
methotrexate therapy [20].  As methotrexate is contraindicated during pregnancy and the pre-
conception period [21], it is unlikely that women who were pregnant or considering pregnancy were 
included in this study sample.  As shown in Table 2, 5 papers reported studies that recruited only 
older age groups (people aged 50 years and over [22-24], people aged 55 years and over [25], or 
people aged 65 years and over [26]), thereby likely excluding women of reproductive age.  A 
further 10 studies did not report detailed eligibility criteria [27-36]. 
 
Studies that included relevant intervention components 
Of the 68 included papers, only 1 (1%) explicitly evaluated pregnancy-focused education (Table 3).  
Eight studies (12%) described interventions containing a minor component that could be 
considered relevant to conception, contraception, pregnancy or breastfeeding, within broader RA 




Meade et al [37] recently published the results of their RCT describing the development and 
evaluation of a ‘motherhood choices decision aid’ for RA.  The Australian decision aid tool was 
designed to assist women with RA in making informed choices about having children, or having 
more children.  Health professionals and women with RA and their partners were involved in the 
development of this resource which includes information on RA, pregnancy and medications, 
decision-making activities, and links to available resources [38].   
 
Information regarding medication safety 
In their study, Fraenkel et al [39] tested a web-based decision support tool designed to inform 




current lack of information about the effect of biologic medications on an unborn child and advised 
participants to inform their doctor prior to commencing therapy if they were pregnant, planning a 
pregnancy, or breastfeeding.  Li et al [20] evaluated a web-based methotrexate decision aid for 
people with RA that incorporated a value clarification module and an information module.  The 
value clarification module asked participants to rate the perceived importance of a set of 
statements; this information was then provided to the rheumatologist to facilitate discussion 
regarding methotrexate use.  As part of this module, participants were asked to rate the importance 
of becoming pregnant (or their partner becoming pregnant) over the next 12 months.  The 
accompanying education module covered 6 key topics including planning a family and 
methotrexate use.  Ciciriello et al [40] designed a multimedia patient education program that aimed 
to improve patient knowledge about methotrexate treatment for RA.  This program included content 
regarding contraindications to taking methotrexate, situations where methotrexate should be 
ceased, and precautions relating to the use of methotrexate in the context of conception and 
breastfeeding.   
 
Information about fertility and contraception 
Although Homer et al [19] excluded women who were pregnant or breastfeeding from their study of 
DMARD education, the authors reported that they sought permission from participants for group 
discussions about fertility and contraception.  Participants in this study were also offered the option 
of discussing these issues privately after the education session, or via a nurse helpline.  In their 
study, Mohammad et al [33] administered a methotrexate patient information booklet.  While the 
content of the information booklet was not specified, the authors indicated that contraception use 
and the side effect profile of methotrexate were outlined in the booklet. 
 
Information about relationships and sexual advice 
In a study of occupational therapy for people with early RA, Hammond et al [41] offered optional 
intervention program components that included sexual advice, and discussion about the effect of 
RA on relationships.  In a later unrelated study, Hammond and colleagues [42] evaluated a 




impact of arthritis on the family.  Finally, the study by Ellard et al [34] evaluated the effect of 
targeted education for people with RA and their partners, provided in the form of day-long 
workshops.  One of the workshops involved small-group discussions on relationships, led by a 
specialist registrar and a psychologist.   
 
Studies that utilised relevant outcome measures 
Of the 9 studies that incorporated a pregnancy-related intervention component, 5 utilised a relevant 
outcome measure to assess patient knowledge or satisfaction.  Ciciriello and colleagues [40] 
developed the Methotrexate in Rheumatoid Arthritis Knowledge test (MiRAK) and used this to 
evaluate changes in knowledge after viewing of their methotrexate multimedia patient education 
program.  This instrument contains 4 items that assess patient understanding of whether it is safe 
to take methotrexate during pregnancy and breastfeeding, whether it is safe to become pregnant 3 
weeks after methotrexate therapy has been ceased, and contraceptive use for men and women 
taking methotrexate.  The MiRAK instrument was also used to evaluate patient knowledge in the 
methotrexate decision aid study by Li et al [20].  Homer et al [19] used the Satisfaction with 
Information about Medicines Scale (SIMS) [43] in their study.  The SIMS contains items relating to 
whether adequate information was given about unwanted effects of medication, the risks of side 
effects, and the impact of medications on an individual’s sex life.  Meade et al [37] described the 
development of a new Pregnancy in Rheumatoid Arthritis Questionnaire (PiRAQ) designed to 
assess knowledge outcomes in their RCT.  The PiRAQ contains 39 items that cover knowledge 
around RA and its impacts, the effects of RA medicines during conception, pregnancy and 
breastfeeding, and post-natal aspects.   The study by Mohammad et al [33] used a questionnaire 
that assessed awareness of the reason for taking folic acid and awareness of contraception use 






This is the first systematic review of interventions designed to improve knowledge and/or self-
management skills concerning contraception, pregnancy and breastfeeding in people with RA.  We 
only identified one study [37] that specifically evaluated pregnancy-focused education or self-
management support for people with RA, revealing a critical gap in the published literature.  
Additionally, most studies (88%) evaluating broader RA education or self-management programs 
did not include any interventional component relating specifically to family planning, pregnancy or 
breastfeeding.  There is, therefore, considerable scope to develop targeted resources or programs 
to effectively support women with RA and their families in negotiating the potentially complex 
journey to parenthood.   
 
Our review also identified that most of the research evaluating education or self-management 
interventions for people with RA has involved older individuals, with average ages for the included 
studies ranging up to 79 years (Online Resource 1).  Although women constituted the majority of 
participants in all of these studies, it is clear that these study samples are not representative of 
younger women with RA who are likely to be making decisions about contraception and 
pregnancy.  Importantly, several studies excluded people aged 50 years or less, while others 
explicitly excluded women who were pregnant or breastfeeding.  Consequently, the outcomes of 
these broader RA programs are unlikely to be generalisable to women who are currently pregnant 
or planning pregnancy.  Notably, our earlier qualitative research highlighted that the specific 
information needs of younger women (such as managing a pregnancy with RA) were not being 
appropriately addressed [7] and this is supported by the results of this systematic review.  This 
finding is of particular relevance given key recommendations from a recent European League 
Against Rheumatism (EULAR) taskforce report that patient education for people with inflammatory 
arthritis should be needs-based and tailored to individual life circumstances [8], and our previous 
research demonstrating the strong preference of younger women with RA not to be grouped with 





The recent study by Meade et al [37] involved women with RA who were contemplating having 
children (or more children).  This research found that participants who were given a motherhood 
decision aid resource had a greater increase in knowledge around RA and pregnancy-related 
topics and a greater reduction in decisional conflict, compared to a no intervention control group.  
However, follow-up of participants beyond the immediate post-intervention period was not 
undertaken and both the relatively high dropout rate (23%) and absence of an intention-to-treat 
analysis should be considered when interpreting the study results.  Despite some limitations in the 
quality of evidence provided by this study, it suggests that a decision aid could present a valuable 
resource for women with RA and their families, consistent with Cochrane review evidence 
demonstrating that decision aids can reduce decisional conflict in people facing health treatment or 
screening decisions [44].  An evaluation of the motherhood decision aid’s effectiveness in clinical 
practice is now warranted.   
 
Where relevant intervention components were identified in the other included studies, many of 
these were limited to medication safety (particularly around methotrexate use) rather than adopting 
a broader self-management paradigm to address disease-related problem solving skills, resource 
utilisation and patient-health professional relationships [10] in relation to reproductive and post-
natal issues.  While medication safety has been identified by women with RA as a key educational 
priority for them [7], this narrow focus does not address other important aspects of effective chronic 
disease management.  Research from our group and others has shown that women with RA can 
struggle profoundly during the post-natal period [14,45] and that they seek practical strategies and 
emotional support to enable them to cope with caring for a young baby [7].  Although some 
interventions included discussions regarding the impact of arthritis on the family and relationships, 
it is clear that information and support spanning the entire pre-pregnancy/pregnancy/post-natal 
continuum is needed.  This could be provided via multidisciplinary approaches incorporating 
primary care, rheumatology and obstetrics input.  Peer support from women with RA who have 
already experienced pregnancy could also form an important part of a targeted educational 
program.  Future research evaluating new interventions should consider carefully how best to 




the management of RA in the context of family planning and pregnancy.  Aside from medication-
focused tools (such as the MiRAK), the Educational Needs Assessment Tool (ENAT) could be 
used to assess potential educational needs including how arthritis might affect one’s children, the 
ways arthritis is affecting an individual, and the side-effects of medications [46].  The new PiRAQ 
tool could be valuable for evaluating pregnancy-related knowledge outcomes, although further 
psychometric evaluation is likely needed [37].  
 
The findings of our systematic review have several implications for practice.  A recent paper 
reporting the proceedings of a multi-disciplinary American College of Rheumatology Reproductive 
Health Summit highlighted the importance of pregnancy planning and pre- and post-natal 
counselling for women with autoimmune and systemic inflammatory conditions [47].  However, 
given the paucity of educational interventions with demonstrated effectiveness, the onus is on 
treating clinicians (for example, primary care physicians, rheumatologists, obstetricians and/or 
pharmacists) to provide relevant information to women who are pregnant or planning a pregnancy.  
While provision of information remains a key component of clinical care (including team-based 
care) [48] and several online medication resources are available [47], these may not be sufficient 
for reinforcing key messages.  For example, a recent clinical audit of sexually active women with 
rheumatologic conditions including RA found that only 57% of women on known teratogenic 
DMARDs were using effective contraception despite receiving specialist rheumatology care at a 
large teaching hospital [49].  A hospital-based study in Turkey also highlighted suboptimal 
contraceptive use among female patients with RA [50].  Appropriate education and support should 
also be made available outside the clinical setting as information seeking may not coincide with the 
timing of clinical consultations.  Additionally, decisions regarding pregnancy in the context of RA 
can require considerable contemplation over time, and women may want to involve their partners 
and others who may not be able to attend clinic appointments.  Educational programs and 
resources that can be accessed outside the clinical setting (such as the motherhood choices 
decision tool [38]) would also be of considerable value to clinicians as there is often inadequate 
time to cover all the educational aspects of RA medications within consultations.  There is also a 




remote areas, and those who may be unable to travel (for example due to illness, functional 
limitations or advanced pregnancy).  As suggested by Kavanaugh and colleagues [47], there is 
also potential for consumer organisations to partner and co-develop ‘risk communication tools’ 
regarding pregnancy and chronic conditions.    
 
We acknowledge several limitations to our research.  We searched the published, peer-reviewed 
literature and it is possible that reports of other interventions may exist in the grey literature, or that 
other effective, unpublished programs may be available in clinical or community settings.  We also 
acknowledge that our determination of relevant intervention components was based on information 
provided in the published papers.  Several of the included studies stated that they provided 
education regarding medication use or side effects as part of their intervention program and this 
may have feasibly included information relating to pregnancy or breastfeeding, although it was not 
explicitly mentioned.   Finally, we did not grade levels of evidence or apply a risk of bias filter to the 
included studies since outcomes data were not extracted. 
 
In conclusion, the current evidence base of effective, published interventions to inform and support 
women with RA and their families during their reproductive years is extremely limited and the 
quality of evidence for specific interventions is modest.  There is significant scope to develop and 
evaluate new programs designed to improve knowledge and self-management skills in this area.  
Future models of education and support should encompass more than just the medication safety 
aspect of RA education and span the entire pre-pregnancy/pregnancy/post-natal continuum in 
order to be of most value to women with RA and their families. 
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Study design, n (%)  
  RCT* or cluster RCT 45 (66) 
  Non-randomised prospective study† 19 (28) 
  Pilot RCT 3 (4) 
  Mixed-methods study 1 (1) 
Study region, n (%)   
  Europe 30 (44) 
  North America 28 (41) 
  Australia and Asia 7 (10) 
  Africa and Middle East 2 (3) 
  South America 1 (1) 
Study setting, n (%)  
  Hospital or rheumatology clinic / centre / practice 40 (59) 
  General community 14 (21) 
  Community health or rehabilitation centre 7 (10) 
  Other 6 (9) 
  Primary care 1 (1) 
Range of sample sizes# 17-921 
Range of mean/median ages# 31-79 
Range of % of participants with rheumatoid arthritis#  12-100 
Range of % of female participants#   60-100 
RCT: Randomised controlled trial 
* 1 paper reported the results of 2 separate RCTs 
† Includes cohort, quasi-experimental and pretest-posttest repeated measures designs 





Table 2.  Studies with exclusion criteria related to pregnancy, breastfeeding or age 
First author Year Study population Relevant exclusion criteria  Intervention(s) 
Davis [26] 2008 People with arthritis 
including RA 
People <65 years 4-month Goal Attainment Pain 
Management Program 
Giraudet-Le Quintrec* [17] 2007 People with RA Pregnancy 8-week intensive education program 
Homer [19] 2009 People with RA or PsA Pregnant women  
Nursing mothers 
Provision of individual or group 
information about DMARDs 
Laforest† [23] 2008 People with OA or RA People <50 years 6-week self-management program 
Laforest† [24] 2012 People with OA or RA People <50 years Provision of social reinforcement after 
a 6-week self-management program 
Li [20] 2014 People with RA Only included people who 
were rheumatologist-
confirmed candidates for 
methotrexate 
Web-based patient methotrexate 
decision aid  
Mayoux-Benhamou* [18] 2008 People with RA Pregnancy 8-week intensive education program 
Nour† [22] 2006 People with OA or RA People <50 years 6-week self-management program 
Pariser [25] 2005 People with OA or RA People <55 years 6-week telephone-based arthritis self-
management program 
DMARDs: Disease-modifying anti-rheumatic drugs; OA: Osteoarthritis; PsA: Psoriatic arthritis 
*Related studies (Mayoux-Benhamou et al 2008 reports a post-hoc analysis) 






Table 3.  Studies including relevant intervention components and outcome measures 
First author Year Study design Relevant intervention 
component  
Relevant outcome measure 
Ciciriello [40] 2014 Non-randomised prospective study Multimedia patient education 
program contained information 
about methotrexate use, 
conception and breastfeeding 
MiRAK† 
Ellard [34] 2009 Non-randomised prospective study Education day for people with 
RA and their partners included a 
workshop on relationships 
No 
Fraenkel [39] 2012 Non-randomised prospective study Interactive online educational 
module contained a warning 
regarding biologics, pregnancy, 
pregnancy planning and 
breastfeeding 
No 
Hammond* [41] 2004 RCT Optional program components 
(to meet individual needs) 
included discussing the effect of 
RA on relationships, and sexual 
advice 
No 
Hammond* [42] 2008 RCT Education modules included 
discussion of impact of arthritis 
on the family 
No 
Homer [19] 2009 Pilot RCT Discussion about contraception 
and fertility 
SIMS 
Li [20] 2014 Mixed-methods study Decision aid information module 
addressed planning a family 
and methotrexate 
Decision aid value clarification 
module incorporated rating the 
importance of becoming 
pregnant / starting a family 
MiRAK 
Meade [37] 2015 RCT Forty-five page motherhood 
decision aid tool for women with 




2009 Non-randomised prospective study Methotrexate patient information 
booklet outlining contraception 
use and side effect profile  
Awareness of contraception 
use 
Folic acid use and 
awareness of reason for 
taking folic acid 
MiRAK: Methotrexate in Rheumatoid Arthritis Knowledge test; PiRAQ: Pregnancy in Rheumatoid Arthritis Questionnaire; SIMS: 
Satisfaction with Information about Medicines Scale; RCT: Randomised controlled trial; RA: rheumatoid arthritis 
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